Patient Care

2. Name: Dr Shalini Singh

3. Designation:  

4. Qualifications :  

5. Email ID :- This email address is being protected from spambots. You need JavaScript enabled to view it.

6. Field of Interest

Consultation Liaison Addiction Psychiatry

Management of alcohol dependence in those with alcohol related liver disease

Safe use of opioids for management of chronic non-cancer pain

Viral hepatitis in those who inject drugs: improved screening protocols

Prevention of substance use disorders

Student wellness

Training of healthcare professionals in management of substance use disorders

7. Total number of publications till date: >40

8. Details of publications since 2010 onwards (the full citation)- these should be divided into journal  articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications)

Journal articles:

1. Balhara YPS, Sarkar S, Singh S. Medical Use, Decriminalization, and Legalization of Narcotic Drugs and Psychotropic Substances—What Does It Mean and What Is Its Current Status in India? Indian Journal of Psychological Medicine. 2022;0(0). doi:10.1177/02537176221138496

2. Jaiswal P, Mahey R, Singh S, Vanamail P, Gupta M, Cheluvaraju R, Sharma JB, Bhatla N. Psychological impact of suspension/postponement of fertility treatments on infertile women waiting during COVID pandemic. Obstet Gynecol Sci. 2022 Mar;65(2):197-206. doi: 10.5468/ogs.21254. Epub 2022 Jan 20. PMID: 35045244; PMCID: PMC8942756.

3. Singh S, Dhawan A. Problematic substance and internet use among medical students. Indian J Soc Psychiatry 2021;37:172-7

4. Choudhary N, Singh S, Rathore P, Ambekar A, Bhatnagar S. Opioid Use Disorders among Patients on Long-Term Morphine for Management of Chronic Cancer Pain: A Pilot Study from a Tertiary Palliative Care Facility. Indian J Palliat Care. 2021 Apr-Jun;27(2):264-268. doi: 10.25259/IJPC_358_20. Epub 2021 Aug 12. PMID: 34511794; PMCID: PMC8428893.

5. Bhatnagar S, Kumar S, Rathore P, Sarma R, Malhotra RK, Choudhary N, Thankachan A, Haokip N, Singh S, Pandit A, Vig S, Ratre BK, Mohan A, Lorenz K, Guleria R. Surviving COVID-19 is Half the Battle; Living Life with Perceived Stigma is Other Half: A Cross-Sectional Study. Indian J Psychol Med. 2021 Sep;43(5):428-435. doi: 10.1177/02537176211029331. Epub 2021 Aug 11. PMID: 34584309; PMCID: PMC8450733.

6. Tripathi R, Singh S, Sarkar S, Lal R, Balhara YP. Pathway to care in co-occurring disorder and substance use disorder: an exploratory, cross-sectional study from India. Advances in Dual Diagnosis. 2021 Feb 8.

7. Tripathi R, Singh S, Bhad R. The need, scope, challenges, and potential solutions for enhancing addiction psychiatry training in India. Indian Journal of Psychiatry. 2020 Nov 1;62(6):728.

8. Dhagudu NK, Ambekar A, Agrawal A, Rao R, Mishra AK, Jain R, Singh S. Is there enough naloxone to deter the diversion? Effect of concurrent administration of intravenous naloxone on opioid agonist effects of intravenous buprenorphine: A randomised, double-blind, within-subject, crossover study among opioid-dependent subjects. Drug Alcohol Rev. 2020 Jul;39(5):595-603. doi: 10.1111/dar.13057. Epub 2020 Mar 11. PMID: 32162420.

9. Balhara YPS, Singh S, Kalra S. Pragmatic Opioid Use in Painful Diabetic Neuropathy. Eur Endocrinol. 2020 Apr;16(1):21-24. doi: 10.17925/EE.2020.16.1.21. Epub 2020 Feb 4. PMID: 32595765; PMCID: PMC7308105.

10. YPS Balhara, Harshwardhan M, Kumar R, Shalini Singh. “Extent and pattern of problematic internet use among school students from Delhi: Findings from the cyber awareness programme,” Asian Journal of Psychiatry (2020),

11. Rao R, Varshney M, Singh S, Agrawal A, Ambekar A. Mental Healthcare Act, 2017, and addiction treatment: Potential pitfalls and trepidations. Indian J Psychiatry. 2019 Mar-Apr;61(2):208-212. doi: 10.4103/psychiatry.IndianJPsychiatry_463_18. PMID: 30992618; PMCID: PMC6425793.

12. Balhara YPS, Singh S, Sarkar S. Are the Patients Ready for the Change?: An Empirical Study to Evaluate the Impact of Change in Formulation of Buprenorphine-Naloxone on Prescription Pattern, Treatment Adherence, and Patient Satisfaction. Subst Use Misuse. 2019;54(2):307-314. doi: 10.1080/10826084.2018.1517799. Epub 2018 Dec 4. PMID: 30513249.

13. Nandan Choudhary, Sushma Bhatnagar, Atul Ambekar, and Shalini Singh. “A cross-sectional study to measure rate of opioid use disorder in patients on long-term opioid analgesic therapy for management of chronic cancer pain. Oral Presentation Abstracts.” Indian Journal of Palliative Care 24, no. 2 (2018): 207–27. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915891/.

14. Shalini Singh, Rakesh Lal, Dinu Chandran, KK Deepak. “Reduced heart rate variability in alcohol use disorder: relationship with severity of depressive symptoms in post acute alcohol withdrawal state : Young Psychiatrist Award, Indian Journal of Psychiatry 60, Supplement 1 ( Febuary, 2018): 2

15. Shalini Singh, Sonali Jhanjee, Deepak Yadav. “Illness narratives of female substance user from an Indian Urban slum a clinical and social perspective on presentation and rehabilitation "College of Problems on Drug Dependence Annual Meeting Abstract Book ( 2017) pg. 325

16. Shalini Singh. “Illness Narratives of Substance Users from Urban India: The Untold Stories of Their ‘Afflictions.’” Medicine Anthropology Theory | An Open-Access Journal in the Anthropology of Health, Illness, and Medicine 4, no. 3 (September 28, 2017): 173.

17. Shalini Singh, Ganesh Kumar Mallaram, and Siddharth Sarkar. “Pathological Gambling: An Overview.” Medical Journal of Dr. D.Y. Patil University 10, no. 2 (March 1, 2017): 120. https://doi.org/10.4103/0975-2870.202105.

18. Shalini Singh, and Yatan Pal Singh Balhara. “A Review of Indian Research on Co- Occurring Cannabis use Disorders & psychiatryc Disorders " Indian Journal of Medical Research 146 no. 2( Feb.1, 2017) 186  https://doi.org/10.4103/ijmr.IJMR_791_15.

20. Shalini Singh & Siddharth Sarkar. “Benzodiazepine abuse among the elderly.” Journal of Geriatric Mental Health [serial online] 2016 [cited 2017 Mar 10]; 3:123-30. DOI: 10.4103/2348-9995.195605

21. Tamonud Modak, YPS Balhara, Shalini Singh. ”Correlation Between Severity of  Alcohol Use Disorder & Disability Among Persons Seeking Treatment at a Tertiary care Drug Dependence Treatment Center Free paapers " Indian Journal of Psychiatry 58, no. 5 ( Jan.1, 2016): 41

22. YPS Balhara, Tamunod Modak, Shalini Singh. “Can IDEAS be used to assess disability among individuals with alcohol use disorder?: Findings from a cross-sectional observational study Free papers.” Indian Journal of Social Psychiatry 32, no. 4 (2016):

23. YPS Balhara, Shalini Singh, Modak T, Sarkar S. “A cross- sectional study to assess disability and its correlates among treatment seeking individuals with alcohol use disorders.” Indian Journal of Psychological Medicine 39 (2017): 40-5.

24. Yatan Pal Singh Balhara, Ashwani Mishra, Hem Sethi, Shalini Singh, and Sudhir Kumar Khandelwal. “Time Trends of Cannabis Use Among Treatment-Seeking Individuals at Government De-Addiction Centers Across India Over a Period of 7 Years.” Indian Journal of Psychological Medicine 38, no. 4 (2016): 331–35. https://doi.org/10.4103/0253-7176.185961.

25. Yatan Pal Singh Balhara, Shaul Lev-Ran, José Martínez-Raga, Amine Benyamina, Shalini Singh, Lisa Blecha, and Nestor Szerman. “State of Training, Clinical Services, and Research on Dual Disorders Across France, India, Israel, and Spain.” Journal of Dual Diagnosis 12, no. 3–4 (October 1, 2016): 252–60. https://doi.org/10.1080/15504263.2016.1254309.

26. Shalini Singh, and Yatan Pal Singh Balhara. “A Review of Indian Research on Co- Occurring Psychiatric Disorders and Alcohol Use Disorders.” Indian Journal of Psychological Medicine, Indian Journal of Psychological Medicine 38, 38, no. 1, 1 (February 2016): 10, 10–19. https://doi.org/10.4103/0253-7176.175089, 10.4103/0253- 7176.175089.

27. Shalini Singh, SK Sinha, R Saha, Mukesh Jha, and DK Kataria. "Knowledge, attitude and practice related to tobacco use and cessation among young medical professionals." Indian Journal of Social Psychiatry 30, no. 1-2 (2014): 35-42.

28. Mina, Shaily, Masarat Jabeen, Shalini Singh, and Rohit Verma. “Gender Differences in Depression and Anxiety Among Atopic Dermatitis Patients.” Indian Journal of Dermatology 60, no. 2 (2015): 211. https://doi.org/10.4103/0019-5154.152564.

29. Budania, Satish Kumar, Monika Rathi, Shalini Singh, and Suresh Yadav. “Serum Cholesterol and Depression: A Puzzle Never Finished.” Journal of the Scientific Society 42, no. 2 (May 1, 2015): 59. https://doi.org/10.4103/0974-5009.157023.

30. Shruti, Aggarwal, Shalini Singh, and Dinesh Kataria. “Knowledge, Attitude and Social Distance Practices of Young Undergraduates towards Mental Illness in India: A Comparative Analysis.” Asian Journal of Psychiatry 23 (October 1, 2016): 64–69. https://doi.org/10.1016/j.ajp.2016.07.012.

31. Tarun Yadav & Shalini Singh. “Transient lesion in the splenium of corpus callosum in a case of acute psychosis with catatonia: pathophysiological hypothesis and literature review. RANZCP Abstracts.” Australian & New Zealand Journal of Psychiatry 47, no. 1_suppl (May 1, 2013): 1–98. https://doi.org/10.1177/0004867412486854.”. Australian & New Zealand Journal of Psychiatry 47 (May 2013): 1-98. 9.

32. Shalini Singh, Shruti Aggarwal, Suman Kumar Sinha, and Dinesh Kataria. "How are you feeing today doctor? Mental wellbeing of young medical professionals: A cross- sectional analysis. Free papers (posters).” Indian Journal of Psychiatry 56, no. Suppl 1 (January 2014): S63–96. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943346/. 

33. Buttar, Navtej S., Cathrine J. DeMars, Gwen Lomberk, Sumera Rizvi, Juliana Bonilla-Velez, Shalini Achra, Shahrooz Rashtak, Kenneth K. Wang, Martin E. Fernandez- Zapico, and Raul Urrutia. “Distinct Role of Kruppel-like Factor 11 in the Regulation of Prostaglandin E2 Biosynthesis.” The Journal of Biological Chemistry 285, no. 15 (April 9, 2010): 11433–44. https://doi.org/10.1074/jbc.M109.077065.

Book chapters:  

34. Shalini Singh. (2022) Women and Mental Health. In: Chadda RK et al (eds.) Mental Health at Crossroads, challenges and solutions. Chandigarh: White falcon Publishing. 139-145.

35. Shalini Singh. (2022) Women and Mental Health. In: Chadda RK et al (eds.) Mental Health at Crossroads, challenges and solutions. Chandigarh: White falcon Publishing. 139-145.

36. Rakesh Lal, and Shalini Singh. “Assessment Tools for Screening and Clinical Evaluation of Psychosocial Aspects in Addictive Disorders.” Indian Journal of Psychiatry 60, no. 8 (January 1, 2018): 444. https://doi.org/10.4103/psychiatry. Indian Journal of Psychiatry_12_18.

37. Dhawan A, Singh Shalini. Social Dimensions of Substance Use Disorders. In: RK Chadda, Vinay Kumar, Nitin Gupta, SiddharthSarkar (eds) Social Psychiatry: Principles and Clinical Perspective, New Delhi: Published by Jaypee Brothers; 2018: 217-226.

38. Yatan Pal Singh Balhara & Shalini Singh. “The relationship between schizophrenia, anti-psychotics and dysglycemia.” In "RSSDI-Annual Conference Update 2015". Chapter91: 438-445.

39. Yatan Pal Singh Balhara & Shalini Singh. ““Psychosociology of diabetes mellitus” In ‘RSSDI-Textbook of Diabetes Mellitus’.Chapter 42: 312-325.

Books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications)

40. Review of the national policies on narcotic drugs and psychotropic substances across the South East Asia region.  Principle Investigator- Yatan Pal Singh Balhara. Duration- 2 months (June- July 2018). Funding Agency- World Health Organisation- South East Asia Regional Office. WHO- SEARO publication

41. Balhara YPS, Singh S. (2018). Recommendations on identification and management of behavioral addictions. Report submitted to WHO SEARO for publication.

42. Shalini Singh, YPS Balhara. “What makes patients with co-occurring psychiatric and substance use disorder complete in-patient treatment: Findings from a tertiary care treatment centre in India” presented at the First National Conference on Addiction Psychiatry – 2017, New Delhi.

43. Balhara YPS, Singh S, Indrakamhaeng D. A situation analysis of the status of policy plans and Programme for addressing depressive disorders among persons with physical Non-Communicable Diseases (NCDs) and substance use disorders across the WHO South East Asian Region (SEAR). WHO SEARO publication.

44. YPS Balhara, Shalini Singh, Arpit Parmar, Ratika Sharma (2016). “To assess burden and socio-economic cost associated with alcohol use among individuals seeking treatment at a substance use disorder treatment centre.” WHO SEARO publication

45. YPS Balhara, Shalini Singh. (2016).  “Review of secondary and tertiary prevention strategies for prevention of illicit substance use disorders. WHO SEARO publication

46. YPS Balhara, Shalini Singh. (2016).  “Review of primary prevention strategies for prevention of illicit substance use disorders. WHO SEARO publication

9. Presentations made at scientific meetings/ conferences/ workshops

10. Investigator/ Co-investigator in funded projects along with year completed/ongoing

As principal investigator:

As co-investigator

1. Investigator/Co-investigator in non-funded projects along with year and title completed/ongoing

12. Thesis supervised for MD/ DM/PhD

- as guide 1  

-as co-guide 5

13. Awards and Honours

1. Selected as Associate Fellow of the National Academy of Medical Sciences in September, 2022

2. Awarded 1-year trainee fellowship of American Academy of Addiction Psychiatry (member no. 2582) from January- December 2018.

3. Winner, Post-graduate debate at the National Conference of Addictio Psychiatry in 2017

4. Awarded the American Association of Addiction Psychiatry (AAAP) 2017 International Trainee Travel Scholarship

5. Travel award by the Indian Council of Medical Research under the International Travel Support for young scientist scheme in the year 2017

6. Awarded fellowship of ‘Course for Academic Development of Psychiatrists’ by the Japanese Young Psychiatrist Organization in Japan, February 2016.

7. Travel award by Science & Engineering Research Board (SERB), Government of India under the International Travel Support Scheme for young scientist - 2015

8. Best Presenter award at the National P.G. Development Program - 2012, Indian Psychiatric Society

14. Any other relevant information

• Book co-editor : Guidelines for Assessment and Treatment of Substance Use Disorders: A Handbook for IRCAs.

• Instructor in online training for clinical staff (Doctors, Counsellors and Nurses) of Ministry of Social Justice and Empowerment (MoSJE) supported IRCAs and ODICs: as part of funded project by the Ministry of Social Justice and Empowerment.

• Invited talk in lecture series: Can a neighbourhood fall sick? Opioid addiction, collective violence, and currents of death in contemporary India. Organised by CSDS (Centre for Study of Developing Societies, India) in January 2021.

• Organising committee member of the first national conference of the Addiction Psychiatry Society of India (APSI) held in January 2021

• Instructor in Capacity Building Training program on Standard Treatment Guideline for the Management of Substance Use Disorder, Government of Odisha. Training program held in January, 2021

• Co-ordinator and resource person for Programme on Orientation of Psychiatrists (Resource Persons) on Management of SUD, Ministry of Health and Family Welfare, October 2020

• Resource person for Wellness symposia for Undergraduate and postgraduate students: “MATE (Mind Activation Through Education)” AIIMS, AIIMS Student Wellness Program, throughout later half of 2020

• Invited lecture in Project LEAD: training program for medical professionals on ‘Alcohol related Liver Diseases’, Institute of Liver and Biliary Sciences, September 2020

• Co-contributor on report and advisory document on Need of reforms in the Drug Policies of India: Decriminalization of personal consumption of drugs for the Ministry of Health and Family Welfare in collaboration with Narcotics Control Bureau (NCB), Ministry of Home Affairs, Government of India. Specific component: “International perspective and study of prevalent model in other countries and appropriate reforms in our laws for reform and rehabilitation of drug addicts”. November 2020.

• Development of public service announcement and resource material for general public regarding tobacco and alcohol use during lockdown period in 2020 for the Ministry of Health and Family Welfare website. April, 2020

• Peer reviewer for following journals:

  • Frontier’s sociology

  • International Journal of Mental Health and Addiction

  • Indian Journal of Social Psychiatry

1. NAME: Dr. BISWADIP CHATTERJEE

2. NAME in HINDI: डॉ. विश्वदीप चटर्जी

3. Designation: Additional Professor of Psychiatry, NDDTC and Department of Psychiatry

4. Designation in Hindi: अपर प्रोफ़ेसर, राष्ट्रीय व्यसन उपचार केंद्र

5. Qualifications: MBBS; M.D. (PSYCHIATRY)

6. Email ID: This email address is being protected from spambots. You need JavaScript enabled to view it. ; This email address is being protected from spambots. You need JavaScript enabled to view it.

7. Field of interest:

• Biological and genetic aspect of addictive behaviours

• Substance Use among adolescents and children

• Capacity building in the area of substance use

• Community-based treatment of substance use

8. Speciality clinics and services:

• Adolescent Drug Treatment Clinic

• Rehabilitation Services

• Community Drug Treatment Clinic, Trilokpuri

9. Total number of publications: 47

Full Articles - in indexed journals

• Chatterjee B*, Jain R, Chawla N, Raghav R. Serum Corticotrophin Releasing Factor (CRF) and its correlation with stress and craving in detoxified opioid-dependent subjects. Asian Journal of Psychiatry. 2021 Dec;102964. DOI: 10.1016/j.ajp.2021.102964

• Gupta S, Chatterjee B*, Sarkar S, Dhawan A. Change in the profile of the service utilizers of a community-based drug treatment clinic: a retrospective study from India. Journal of Substance Use. 2021 Aug 22;0(0):1–6. DOI: 10.1080/14659891.2021.1968970

• Jain R, Chatterjee B, Gupta A. Assessment of codeine abuse among substance-abuse patients based on urinalysis: A retrospective study. Asian Journal of Psychiatry. 2021 Aug 1;62:102719. DOI:10.1016/j.ajp.2021.102719

• Singh A, Rao R, Chatterjee B, et al. Cognitive functioning in patients maintained on buprenorphine at peak and trough buprenorphine levels: An experimental study. Asian Journal of Psychiatry 2021;61:102697. DOI: 10.1016/j.ajp.2021.102697

• Bhatia G, Chatterjee B, Dhawan A. Adolescents, Drugs, and COVID-19: Special Challenges During the Pandemic. Indian J Psychol Med. 2021; XX:1–5. DOI: 10.1177/0253717621988998

• Gupta S, Bhatia G, Sarkar S, Chatterjee B, Balhara YP, Dhawan A. Adult attention-deficit hyperactivity disorders and its correlates in patients with opioid dependence: An exploratory study. Indian J Psychiatry 2020;62:501-8. DOI: 10.4103/psychiatry.IndianJPsychiatry_705_19

• Dhawan A, Mishra AK, Ambekar A, Chatterjee B, Agrawal A, Bhargava R. Estimating the Size of Substance Using Street children in Delhi Using Respondent-Driven Sampling (RDS). Asian Journal of Psychiatry 2019. doi: 10.1016/j.ajp.2019.101890

• Singh VV, Gupta S, Sarkar S, Chatterjee B. Problematic dicyclomine use: A case report and narrative review. Asian Journal of Psychiatry 2020;48:101891. doi: 10.1016/j.ajp.2019.101891

• Sagar R, Sahu A, Pattanayak RD, Chatterjee B. Assessment of cognitive functions inipolarI

• disorder: A 1‐year naturalistic follow‐up study. Bipolar Disorder 2018; 20(3): 248–259. doi:10.1111/bdi.12584.

• Chawla N, Mandal P, Chatterjee B, Dhawan A. Tramadol associated Pica: A case report. Psychiatry and Clinical Neurosciences. 2019;73(1):43-43. doi:10.1111/pcn.12789

• Chadda RK, Chatterjee B. Need for psychosocial interventions: From resistance to therapeutic alliance. Indian J Psychiatry 2018;60:440-3

• Sarkar S, Parmar A, Chatterjee B. Substance use disorders in the elderly: A review. Journal of Geriatric Mental Health 2015; 2:74-82

• Sahu A, Gupta P, Chatterjee B. Depression is more than just sadness: A case of excessive anger and its management in depression. Indian Journal of Psychological Medicine. 2014;36(1):77.

• Chatterjee B, Sharan P. Tardive dyskinesia in a pregnant woman with low dose, short-duration risperidone: possible role of estrogen-induced dopaminergic hypersensitivity. J Neuropsychiatry Clin Neurosci. 2014;26(1):E44–46.

• Chatterjee B, Quraishi R, Jain R. Sociodemographic and Drug Use Characteristics of Treatment-seeking Cannabis Users at a Tertiary Care Center in India. Addictive Disorders & Their Treatment. 2013 Apr;1. DOI: 10.1097/ADT.0b013e31828bf7f2

• Quraishi R, Jain R, Chatterjee B, Verma A. Laboratory Profiles of Treatment-Seeking Subjects with Concurrent Dependence on Cannabis and Other Substances: A Comparative Study. International Journal of High-Risk Behaviors and Addiction. 2013 Dec 23;2(3):107–11.

• Chatterjee B, Pattanayak RD, Sagar R. Consultation — liaison in paediatric population. Journal of Mental Health and Human Behaviour 2012; Supp(1):65-71

• Chatterjee B. Smokeless evidence. British Dental Journal 2012 21;213(6):263

• Chatterjee B, Pattanayak RD, Sagar R. Emotional and behavioural issues in a child with leukaemia. Journal of Mental Health and Human Behaviour 2012; Supp(1):101-104

• Chatterjee B, Kumar N, Jha S. Role of Repetitive Transcranial Magnetic Stimulation in Maintenance Treatment of Resistant Depression. Indian Journal of Psychological Medicine 2012;34(3):266-269

Scientific reports:

• Dhawan A, Chatterjee B, Bhargava R, Mandal M, Rao R, Chopra A. Survey on Substance Use Among School and College Students: Report of the focused thematic study. National Survey on Extent and Pattern of Substance Use in India. Ministry of Social Justice and Empowerment (MoSJE), Government of India; 2021

• Dhawan A, Bhargava R, Chatterjee B, Mandal M. Report of Project Screening & Intervention for Drug/ Substance abuse among School going children in New Delhi. Samagra Shiksha, Education Department, GNCT of Delhi, New Delhi, India; 2021.

• Dhawan A, Bhargava R, Chatterjee B, Mandal M, Malhotra S. Extent of Mental Health Issues & Addictive Behavior Among Adolescents Seeking Help in Adolescent Friendly Health Clinics, Delhi. Directorate of Family Welfare, Govt. of NCT Delhi; 2020

• Dhawan A, Ambekar A, Bhargawa R, Mishra A, Agrawal A, Chatterjee B, Chopra A. Mapping and size estimation of street children who use drugs in Delhi. Ministry of Social Justice and Empowerment (MSJ&E), GoI Department of Women & Child Development, Govt. of NCT of Delhi and NDDTC (AIIMS), New Delhi, India; 2016.

Manuals:

• Chatterjee B, Dhawan A, Mishra S. Training module for Child Welfare Police Officers (CWPO) on adolescent substance use. Ministry of Social Justice and Empowerment, Government of India, New Delhi; 2022.

• Chatterjee B, Dhawan A, Mishra S. Training module for Community based Peer led Intervention (CPLI) workers on adolescent substance use. Ministry of Social Justice and Empowerment, Government of India, New Delhi; 2022.

• Chatterjee B, Dhawan A, Mishra S. Training module for functionaries of Outreach and Drop-In Centre (ODIC) on substance use. Ministry of Social Justice and Empowerment, Government of India, New Delhi; 2022.

• Chatterjee B, Dhawan A, Mishra S. Training module for staffs of Integrated Rehabilitation Centre for Addicts (IRCAs) on substance use. Ministry of Social Justice and Empowerment, Government of India, New Delhi; 2022.

• Dhawan A, Bhargava R, Chatterjee B, Mandal M. Prevention and Intervention for Substance Use in Schools Standard Operating Procedures (SOP) Manual for Government Schools, GNCT of Delhi. Samagra Shiksha, Education Department, GNCT of Delhi, New Delhi, India; 2021.

Book chapters:

• Chatterjee B, Sen MS, Chawla N. Substance use in adolescence. In; Kaloiya GS et al editors. Basics of Addiction Psychology. [ISBN Number: 978-93-5346-328-1]

• Dhawan A, Chatterjee B. Children with Substance Use. In: Kapoor R et al editors. A Handbook on counselling: for Training, and Skill Development of staff of Child Care Institutions (CCIs). Delhi: National Commission for Protection of Child Rights (NCPCR). 2017. P. 42-53

• Sharan P, Chatterjee B. Global burden of mental illness. In: Resource book of the PG Diploma on mental health for IGNOU

Abstracts indexed:

• Kathiresan P, Chatterjee B, Rao R. Night hospitalization as a treatment model for patients with substance use disorders: the concept and its outcome. Indian J Psychiatry 2020:62(SS-1);S20-21

• Jain R, Ghosh S, Chatterjee B. Critical Issues in Alcohol and Drugs of Abuse Testing in De-addiction Programs. Indian J Psychiatry 2020:62(SS-1);S153

• Sagar R, Chatterjee B, Goyal N, Sahu A. Mental Health Promotion and Prevention in school setting: Are we prepared for tomorrow. Indian J Psychiatry 2020:62(SS-1);S154

• Chatterjee B, Kattula D, Bhatia G, Mishra S. Recovery in Addiction Psychiatry: concept and interventions. Indian J Psychiatry 2020:62(SS-1);S67

• Jhanjee S, Mandal P, Chatterjee B. Tobacco use in vulnerable populations in India: A review. Indian J Psychiatry 2020:62(SS-1);S93

• Chatterjee B, Mandal P, Rao R, Kattula D. Rehabilitation of special populations in addiction psychiatry. Indian Journal of Social Psychiatry 2019;35(SS-4):275

• George AB, Chatterjee B. Substance use and road traffic accidents: a review of critical aspects. Indian J Psychiatry 2019:61(SS-3);S593

• Verma K, George AB, Chatterjee B. Inhalant use disorders: A review of Recent research. Indian J Psychiatry 2019:61(SS-3);S584

• Chatterjee B, Quraishi R, Rao R. Genetic aspects of addictive disorders. Indian J Psychiatry 2018:60(SS-1);S26

• Chatterjee B, Dhawan A, Chopra A, Bhargawa R, Pattanayak RD , Tikoo VK. Profile, pattern and correlates of inhalant use among children in India. The Indian Journal of Pediatrics 2017;SS-1:88

• Saini R, Panda UK, Chatterjee B. Stigma and Substance Use Disorders: An Overview. Indian Journal of Social Psychiatry 2017;33(SS-1):S27

• Chatterjee B, Agarwal A, Lenin Singh RK, Adarkar S, Ambekar A, Rao R, Khandelwal S. "Drug Treatment Clinics": A Government of India Scheme to Promote Affordable, Accessible and Quality Addiction Treatment Services in India. Indian Journal of Psychiatry 2016;58 (Supplement):S29

• Jhanjee S, Jain R, Chatterjee B, Mandal P. E-Cigarettes Use: Is it an Acceptable Alternative? Indian Journal of Social Psychiatry 2016; 32(4): 386

• Mandal P, Chatterjee B, Sagar R, Prakash S. Stigma Towards Mentally Ill Among Health Care Staffs in India and Way Forward. Indian Journal of Social Psychiatry 2016; 32(4): 413

• Ganesh R, Chatterjee B. Cannabis Use Disorder: Review of Treatment Options. Indian Journal of Social Psychiatry 2016; 32(4): 459

• Chatterjee B, Mandal P, Sagar R, Kumar N. Attitude towards mentally ill among nursing professionals: Evidence from a tertiary care general hospital. Indian Journal of Psychiatry 2015; 57 (Supplement): S92

• Dhawan A, Chatterjee B, Balhara YPS, Bhargava R. Issues in Child and adolescent substance use. Indian Journal of Psychiatry 2015; 57 (Supplement): S186

• Chatterjee B, Sagar R, Vivekanandan S. Correlation of serum BDNF level with clinical symptom domains in Bipolar Disorder-I. Bipolar Disorders 2014;16(Suppl. 1): 81-82

• Chatterjee B, Sagar R, Vivekanandan S, Sahu A. Association of serum BDNF with verbal and visual memory deficit in subjects with bipolar disorder-I. Bipolar Disorders 2014;16(Suppl. 1): 66

• Chatterjee B, Mandal P, Kumar N, Sagar R. Mental illness: Who do the health professionals blame? Indian Journal of Psychiatry 2013;55(5Suppl 1): S66

• Sahu A, Chatterjee B, Sagar R. Assessment of cognitive impairment and functional disability in euthymic state in type I bipolar disorder: Is the recovery “complete”? Indian Journal of Psychiatry 2013;55(5Suppl 1): S81

9. Presentations made at scientific meetings/ conferences/ workshops:

• Corticotrophin Releasing Factor (CRF) and Its Correlates in Detoxified Opioid-dependent Subjects: A Comparative Study. NIDA International Poster Session at the College on Problems of Drug Dependence (CPDD) Virtual Scientific Meeting; June 23, 2020

• Profile, pattern and correlates of inhalant use among children in India. Presented at: 11th World Congress on Adolescent Health; 27-29 October, 2017. Organized by: International Association for Adolescent Health (IAAH).

• Management for Substance Use among Adolescents across Settings. 1st National Conference of Addiction Psychiatry Society of India ‘ADDICON 2021’; 2021 December 10-11; Delhi, India

• Interventions for Substance use in School Setting: Sharing experiences. 28th National Conference of Indian Association of Social Psychiatry; 2021 November 26–28; Imphal, Manipur, India

• Addressing substance using children and their psychosocial needs. WASP Asia Pacific Hybrid Congress 2021; 2021 September 16-18; New Delhi, India

• Mental Health Promotion and Prevention in school setting: Are we prepared for tomorrow. 72nd Annual National Conference of Indian Psychiatric Society; 2020 January 22-25; Kolkata , India

• Recovery in Addiction Psychiatry: concept and interventions. 72nd Annual National Conference of Indian Psychiatric Society; 2020 January 22-25; Kolkata , India

• Tobacco use in vulnerable populations in India: A review. 72nd Annual National Conference of Indian Psychiatric Society; 2020 January 22-25; Kolkata , India

• Night hospitalization as a treatment model for patients with substance use disorders: the concept and its outcome. Contested for K. C. Dube award in 72nd Annual National Conference of Indian Psychiatric Society; 2020 January 22-25; Kolkata, India

• Critical Issues in Alcohol and Drugs of Abuse Testing in De-addiction Programs. 72nd Annual National Conference of Indian Psychiatric Society; 2020 January 22-25; Kolkata, India

• Rehabilitation of special populations in addiction psychiatry. 26th Conference of Indian Association for Social Psychiatry (NCIASP); 2019, November 30-December 1;Bhubaneswar, India.

• Trends in the Profiles of the Patients Visiting a Community Based Substance Use Treatment Centre in an Urban Resettlement Colony in India: A Retrospective Chart Review. XXI Annual Meeting of the International Society of Addiction Medicine; 2019 November 13-16; New Delhi, India.

• Substance Use in Externalizing Disorders in Adolescence. XXI Annual Meeting of the International Society of Addiction Medicine; 2019 November 13-16; New Delhi, India.

• Intervention for Substance Use among Adolescents Across Settings. XXI Annual Meeting of the International Society of Addiction Medicine; 2019 November 13-16; New Delhi, India.

• Corticotrophin Releasing Factor (CRF) and its correlates in detoxified opioid-dependent subjects: a comparative study. Annual National Conference of Indian Association of Biological Psychiatry (ANCIABP); 2019 September 20-21; Agra, India

• Genetics of Alcohol and Opioid dependence. Prevalence, association and implication on treatment outcome. In: 3rd Global conference of Biological Psychiatry, 23-26 August 2018. Mumbai, India

• Substance use and road traffic accidents: a review of critical aspects. In: 71st Annual National Conference of Indian Psychiatric Society (ANCIPS-2019), 31st January-03rd February, 2019. Lucknow, India

• Inhalant use disorders: A review of recent research. In: 71st Annual National Conference of Indian Psychiatric Society (ANCIPS-2019), 31st January-03rd February, 2019. Lucknow, India

• Genetic aspects of addictive disorders. Presented at: 70th Annual National Conference of Indian Psychiatric Society, 2018; 5-8 Feb 2018. Organized by: Indian Psychiatric Society, Central institute of Psychiatry, Ranchi, India.

• Drug use problem: Focusing on the population groups with specific needs. Presented at: 1st National Conference on Addiction Psychiatry; 27-29 November, 2017. Organized at: National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India

• Beyond drug dependence treatment: facilitating rehabilitation and understanding recovery. Presented at: 1st National Conference on Addiction Psychiatry; 27-29 November, 2017. Organized at: National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India

• Stigma and Substance Use Disorders: An Overview. Presented at: 24th National Conference of Indian Association for Social Psychiatry (NCIASP-2017); 17-19 November 2017. Organized by: Indian Association of Social Psychiatry

10. Funded projects

A. Principal Investigator/Co-PI in funded projects title along with year completed/ongoing

• Role of specific single-nucleotide gene polymorphisms (SNPs) with treatment adherence and outcome with naltrexone among patients with opioid dependence: A naturalistic follow-up study. Funding agency – ICMR. Year and status 2020 (on-going). Funding amount – INR 50,69,576

• Role of genetic polymorphism in determining risk and severity of opioid dependence: A case-control study. Funding agency -Intramural funding from AIIMS. Year and status - 2019 (on-going). Funding amount – INR 10,00,000

• Development of Training Modules on Substance Use for the training of Child Welfare Police Officers, functionaries working in Integrated Rehabilitation Centre for Addicts (IRCAs), Out Reach Drop-in Centre (ODICs) and Community Based Peer Led Intervention (CPLIs). Funding agency - MoSJE, GoI. Year and status – 2021 (completed in December 2022). Funding amount - INR 5,69,576

• A comparative study to assess the autonomic and hemodynamic (fNIRS) changes due to induced stress among detoxified opioid-dependent subjects. Funding agency -Intramural funding from AIIMS. Year and status - 2022 (operative approval awaited). Funding amount - INR 10,00,000

• Comparison of serum Corticotrophin Releasing Factor (CRF) level in detoxified Opioid-dependent subjects with healthy controls. Funding agency – Intramural funding from AIIMS. Year and status - 2017 (completed in April 2019). Funding amount – 2,00,000

B. Co-investigator in funded projects title along with year completed/ongoing

• Training Medical Officers on Treatment of Substance Use Disorders through an Online Training Programme. Source of funding - National Institute of Social Defence, MoSJE, GoI. Year and current status - 2021 (on-going). Total amount - INR 32,60,000/-

• Developing and testing an Online Training Programme for Medical Officers on Treatment of Substance Use Disorders. Source of funding - National Institute of Social Defence, MoSJE, GoI. Year and current status - 2018 (on-going). Total amount - INR 16,48,500/-

• Developing and Implementing Training Mechanism for use of Essential Narcotic Drugs (ENDs) for treatment of Opioid Dependence. Source of funding - ‘National Fund for Control of Drug Abuse, NFCDA’ by the Department of Revenue, Ministry of Finance, Govt. of India. Year and current status - 2017 (on-going) Total amount - INR 76,21,950/-

• Screening and intervention for substance use among school-going children in Delhi. Source of funding - Ministry of Human Resource Development (MHRD). Year and current status – 2019 (completed in 2021). Total amount - INR 80,00,000

• Establishing and Implementing Capacity Building Mechanisms for Addiction Treatment Facilities in India. Source of funding - Ministry of Social Justice and Empowerment, Government of India. Year and current status – 2019 (on-going). Total amount - 15,38,00,000

• Scheme for establishing Addiction Treatment Facilities (ATFs) in Govt Hospitals. Source of funding - Ministry of Social Justice and Empowerment, Government of India Year and current status – 2019 (on-going) Total amount - Flexible budget (approx. 62,48,03,025)

• Scheme for Strengthening DDAP: Establishment of DTCs. Source of funding Ministry of Health and Family Welfare, Drug De Addiction Programme (DDAP), GoI. Year and current status – 2014 (on-going) Total amount - Flexible budget (renewal every year)

• Extent of mental health issues and addictive behaviour among adolescents seeking help in Adolescent Friendly Health Clinics (AFHCs) in Delhi. Funding agency – Govt. of India as a part of ROP 2018-19 under National Health Mission. Year and current status - 2018 (completed in 2020). Total amount - 18,85,000

• Survey on substance use among school and college students. Source of funding - MoSJE, GoI. Year and current status - 2017 (completed in 2020). Total amount - Approx. INR 20 lakhs

• Mapping and size estimation of the street children who use drugs in Delhi. Funding agency – Ministry of Social justice and Empowerment (MoSJE, GoI) Year and current status - 2015 (completed). Total amount - 18,81,000

11. Non funded projects

1. Principal Investigator/Co-PI in non-funded projects title along with year completed and ongoing

• Retrospective study to analyze the profile, the pattern of substance use and outcome of treatment of adolescent patients who sought treatment for opioid use. Current status: 2022 (on-going)

• COVID-19 experience and literacy among substance use disorder (SUD) patients. Current status: 2022 (on-going)

• Assessment of impact of COVID-19 and related measures on substance use and associated factors among treatment-seeking adults. Current status: 2020 (on-going)

• Assessment of impact of COVID-19 and related measures on substance use and associated factors among treatment-seeking adolescents. Current status: 2020 (on-going)

• Night hospitalization as a model for rehabilitation of patients with substance use disorders. Current status: 2019 (completed)

• Profile of patients seeking treatment at community substance use clinic in an urban resettlement area in Delhi. Current status: 2019 (on-going)

• Predictors of non-adherence to naltrexone maintenance treatment in opioid-dependent individuals. Current status: 2018 (on-going)

B. Co- investigator in non-funded projects title along with year completed and ongoing

• Urinary ethyl glucuronide testing to detect recent alcohol use among opioid-dependent patients maintained on buprenorphine. 2022 (on-going)

• Experience of Patients on Methadone Maintenance Treatment Receiving Take Home Methadone Doses During Covid-19 Pandemic In India: A Mixed-Method Study. Year and current status - 2021 (ongoing)

• A study to assess seroprevalence of viral hepatitis and setting up referral mechanisms for further intervention for persons who inject drugs seeking treatment from an addictive disorders treatment centre. Year and current status 2018 (on-going)

• Adult ADHD in patients with opioid dependence: An exploratory study. Year and current status - 2018 (completed)

• Factors affecting outcome in terms of agonist versus antagonist management in adolescents with opioid dependence. Year and current status - 2017 (on-going)

12. Thesis supervised for MD/ DM:

As guide (number only): Two

As co-guide (number only): Six

• Assessment of clinical and HPA axis hormones in response to stress challenge in buprenorphine-maintained patients: An exploratory study.

• A Pilot Study on Dropouts in Adolescent Outpatients with Substance Use Disorder

• Assessment of clinical and neuroendocrine response to induced stress in detoxified opioid dependent subjects

• Association of Phosphatidylethanol (PEth) Levels with Severity of Alcohol Dependence in Treatment-Seeking Patients of Alcohol Dependence: An Exploratory Study

• Family Functioning and Parenting styles in Adolescent Substance Use

• Assessment of factors associated with short term retention of opioid dependent subjects on oral naltrexone

• Cognitive functioning in buprenorphine maintained opioid dependent patients at peak and trough buprenorphine levels: An experimental study

• A comparative study of pattern and severity of substance use and co-morbidity among out-patient youth and older adult opioid users

13. Significant events/achievements/awards

• Best research paper award for the year 2017-18 on the occasion of the 63rd Institute Day of AIIMS. This award was for publishing the article “Sagar R, Sahu A, Pattanayak RD, Chatterjee B. Assessment of cognitive functions in bipolar I disorder: A 1‐year naturalistic follow‐up study. Bipolar Disorder 2018; 20(3): 248–259. doi:10.1111/bdi.12584.” in journal with highest impact factor.

• “Best stall” award for the year 2018 was won by the Rehabilitation Services of NDDTC as a part of the celebration for the 63rd Institute Day of AIIMS, Delhi.

• Awarded BMJ SOUTH ASIA AWARD 2016 as a team member for “Scheme for Strengthening DDAP: Establishment of DTCs. Ministry of Health and Family Welfare, Drug De Addiction Programme (DDAP)” under the category Best NON-COMMUNICABLE DISEASE INITIATIVE OF THE YEAR

• Recipient of 1st prize for best oral presentation titled “Impact of age at onset on course of Bipolar Disorder - I: A comparative study of early-onset versus adult-onset illness from India” at 13th Congress of ASEAN Federation of Psychiatry & Mental Health; 2012 November 16-17; Singapore.

• Recipient of 1st prize for best poster presentation titled “Comparison of various socio-demographic and attitudinal variables in relation to choice of coercive setting among Para-medical professionals working in a general hospital” at First Indo-European Symposium on Coercion; 2013 February 1-3; Mysore, India.

• Recipient of ICMR Thesis financial assistance under MD/MS/DM/MCH Thesis Financial Assistance Programme of ICMR, Manpower Development.4.

• International Travel Grant Award from ICMR to attend 16th Annual Conference of International Society for Bipolar Disorders. 2014 March 18-21; Seoul , Korea.

2. Name: Dr. Rizwana Quraishi

3. Designation: Additional Professor (Clinical Chemistry), Faculty In-charge, Laboratory Services, National Drug dependence Treatment Center, Department of Psychiatry, AIIMS, New Delhi.

4. Qualifications: M.Sc. (Biochemistry), Ph.D. (Clinical Chemistry)

5. Email ID: This email address is being protected from spambots. You need JavaScript enabled to view it.

6. Field of Interest: 

• Standardization of techniques for health damage assessment (treatment compliance and effectiveness studies).

• Genetic basis of addictive behaviours.

• Testing of Drugs of abuse (DOA) and therapeutic drug monitoring (TDM)

• Translational Research: Field applicable and patient friendly assessment techniques like dried blood assays.

7. Total number of publications till date: 40

8. Details of publications since 2010 onwards (the full citation)-

• Journal  articles (peer reviewed publications)

1. QuraishiR, Sarkar S, Parmar A, JainR, Das BK, AmbekarA. Exploring the clinical variables among drug dependent HIV-Positive: Implications for treatment strategies. Indian J Public Health 2022, 66(3), 331-333.

2. QuraishiR,VarshneyM,RaoA, Ambekar A. Evaluation of alcohol use pattern among OST patents using alcohol biomarkers. Indian J Psychiatry 2022, 64(3), 312-315.

3. Quraishi R, Kathiresan P, Verma K, Rao R, Jain R. Effect of chronic opioid use on the haematological and inflammatory markers: A retrospective study from North India. Indian J Psychiatry 2022;64:252-6.

4. QuraishiR, Sharma J, JainR,AmbekarA. Influence of COMT gene polymorphism on alcohol and tobacco consumption in North Indian treatment seeking population. Indian J Psychiatry 2021, 63(3), 240-244-315.

5. Quraishi R, Sarkar S, Jain R.Impact of chronic alcohol and opioid dependence on biochemical parameters: A retrospective case control study from a tertiary care treatment centre in North India. Addict Health 2021;13(3):148-55.

6. QuraishiR,VarshneyM,SinghA,SinghD,KumarM,RaoAetal.Useoffilterpapertomeasurealcoholbiomarkersamongopioiddependent patients on agonist maintenance treatment: A community based study. Indian J Psychol Med 2019, 41(6), 529-34.

7. Jain R, Quraishi R, Verma A, Ambekar A. Development and clinical evaluation of a dried urine spot method for detection of morphine among opioid users. Ind J Pharmacol. 2019, 51(1): 40-44.

8. Jain R, Quraishi R, Verma A. Evaluation of dried urine spot method to screen cotinine among tobacco dependents: An exploratory study. Ind J Psychol Med, 2017, 39(4), 2017: 469-474.

9. Jain R, Quraishi R, Ambekar A, Verma A, Gupta P. Dried urine spots for detection of benzodiazepines.Indian J Pharmacol, 2017, 4(5):1420-1423.

10. Quraishi R, Jain R, Mishra AK & Ambekar A. Association of ANKK I polymorphism with co-morbid alcohol and nicotine dependence: A pilot study from a tertiary care treatment center in North India”. Ind J Med Res 145, January 2017, pp 33-38

11. Quraishi R, Jain R, Ambekar A. Hematological Profile of Alcohol Dependent subjects: Report from a Tertiary Care Treatment Centre in India. Int J Pharma Res Health Sci. 2016; 4 (5): 1420-1423

12. Quraishi R, Lakshmy R, Mukhopadhyay AK, and Jailkhani BL. Transaminase Extraction and Stability from Dried Serum Samples. Schol J Appli Med Sci, 2014; 2 (1B): 169-170.

13. Quraishi R & Jain R. ANKKI/Taq A1 Genotyping from dried blood stored on filter paper among alcohol & nicotine dependantsubjects. British Biomed Bulletin 2014, 2 (1): 263-266.

14. Quraishi R, Jain R, Balhara YPS. Profile of Nicotine Use among Alcohol Dependent Patients Visiting a Tertiary Care Center in North India. Indian J Psychol Med. 2014; 36(2):174-8.

15. Quraishi R, Pattanayak RD, Jain R, Dhawan A. A Descriptive Study of Clinical, Hematological and Biochemical Parameters of Inhalant Users Seeking Treatment at a Tertiary Care Centre In India. Ind J of Psycho Med, 2013; 35(2): 174-179.

16. Chatterjee B, Quraishi R, Jain R.Socio-demographic and drug use characteristics of treatment-seeking cannabis users at a tertiary care centre in India. Add Dis and Their Treat, 2013; 33: 1-3.

17. Quraishi R, Jain R, Chatterjee B, Verma A. Laboratory profile of cannabis dependent treatment-seeking population at a tertiary care centre in India. Int J High Risk Behav Addict. 2013;2(3): 107-11.

18. Quraishi R, Jain R, Anish PK. Naltrexone level and biochemical profile of opiate dependent patients on Naltrexone Maintenance Programme: A pilot study. Add Dis and Their Treat Published ahead of print. 10.1097/ADT.0b013e31827a1ede

19. Quraishi R, Jain R, Ambekar A. The use of dried blood spot samples in screening drugs of abuse. Pharmacology & Pharmacy, 2013, 4, 152-159

20. Quraishi R, Lakshmy R, Mukhopadhyay AK, and Jailkhani BL.Analysis of the stability of urea in dried blood spots collected and stored on filter paper. Annals of Lab Med, 2013; 33: 1-3.

21. Quraishi R, Lakshmy R, Mukhopadhyay AK, and Jailkhani BL. Creatinine measurement and stability in dried Serum.J Diabetes Sci and Tech, 2012 Jul 1; 6 (4): 988-9

22. R Quraishi, R Lakshmy, k Luthara, AK Mukhopadhyay, BL Jailkhani. Apo E Genotyping from blood stored on filter paper. IJMR 2012; 135 (3): 318-321

23. Jain R, Quraishi R, Majumder P, and Pattanayak RD. Comparison of self-report and biological measures for alcohol, tobacco and illicit drug use in consecutive alcohol dependent patients visiting a tertiary care centre. Journal of Substance Use 1-9, Posted online on 19 April 2012.

24. Quraishi R, Jain R, Pattanayak RD. Laboratory Profile of current Injecting Drug Users seeking treatment at a tertiary care centre in India: What do the regular blood tests and HIV screening say?. Add dis and their treat, Early online ahead of publication, December 2011 doi: 10.1097/ADT.0b013e31824040432.

• Books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications)

1. Mishra R, Deep R, Quraishi R, Jain R. Assessment for mitochondrial DNA A10398G polymorphism in Indian patients with bipolar I disorder. Bipolar Disorders (Journal) 2022; 24(S1): pp42 

2. Quraishi R, Jain R, Ambekar A. Use of filter paper in substance abuse treatment setting. Indian J Clin Biochem. 2019, 34 (1): 200.

3. QuraishiR,SinghD,AmbekarA,JainR,RaoR.Gammagutamyltransferasemeasurementindriedserumspots.AlcoholClinical& Experimental Research, 2018; 42 (S2), P1-1-48: 24A.

4. Ambekar A, Singh A, Quraishi R. Substance use disorders Shah N, De Sousa A (eds). A Short Textbook of Psychiatry. Bhalani Book Publishers, Mumbai. First Edition, 2018: pp 221-242. ISBN: 978-93-5311-908-9.

5. Quraishi R, Singh D, Ambekar A, Jain R, Rao R. Gamma gutamyl transferase measurement in dried serum spots. Alcohol Clinical & Experimental Research, 2018; 42 (S2), P1-1-48: 24A.

6. Chatterjee B, Quraishi R, Rao R. Genetic aspects of addictive disorders. Indian J Psychiatry 2018, 60 (supplement 1): S26

7. Quraishi R and Ambekar A. Genetics of alcohol use disorder. In: Dihingia S & Bhuyan D (Ed). Psychiatry Update. Indian Psychiatry Society, Dibrugarh and Psychiatrists of Dibrugarh, Assam. First Edition, 2018: pp 221-242. ISBN: 978-93-5311-908-9

8. Quraishi R, Jain R, Ambekar A. Use of filter paper in substance abuse treatment setting. Indian J Clin Biochem. 2019, 34 (1): 200.

9. Quraishi R, Jain R, Ambekar A. “Dried Blood Spots for Testing Drugs of Abuse” chapter in the book “Analytical testing for substance abuse” Published by The Royal Society of Chemistry, Cambridge, UK, 2017.
   

9. Presentations made at scientific meetings/ conferences/ workshops

1. Quraishi R, Kumar R, Sarkar S, Rao R, Ambekar A.Clinical and biochemical profile of alcohol dependent patients initiated on naltrexone. World Psychiatric Association 3-6 Aug 2022, Bangkok, Thailand.

2. Jain R, Chadda R, Lal R, Rao R, Quraishi R. High-throughput LC-QTOF Mass Method for the detection of designer piperazines in urine of substance users attending the tertiary care treatment center of North India. NIDA International  Forum, Minneapolis June 2022.

3. Mishra R, Deep R, Quraishi R, Jain R. Assessment for mitochondrial DNA A10398G polymorphism in Indian patients with bipolar I disorder. International society for Bipolar Disorders May 2022.

4. Quraishi R, Jain R. Complete blood count of alcohol dependent patients. 4 Dec 2020, Asian Internal Society of Addiction Medicine ( virtual mode)

5. Shukla T, Shani S, Kathiresan P, Quraishi R, Rao R, Jain R, Ambekar R. An observational prospective study assessing factors affecting abstinence with disulfiram treatment in patients with alcohol dependence” on July 2020 at 2^nd International conference of Research and Education Center for mental Health and Psychiatry, Taiwan (virtual mode).

6. Quraishi R, Sarkar S, Sharma A. Genetic underpinning of addiction. Symposium presented at International Society of Addiction Medicine (ISAM 2019),13-16 Nov 2019 in Delhi, India.

7. Quraishi R, Jain R, Ambekar A. Use of filter paper in substance abuse treatment setting. Poster presented at the Asian Pacific Federation of Clinical Biochemistry and Laboratory Medicine (APFCB 2019), 17-20 Nov 2019 in Jaipur, India.

8. Quraishi R, Chatterjee B and Rao R. Genetics of alcohol and opioid dependence: prevalence, association and implications in treatment outcome. Symposium presented at 3^rd Global conference of Biological Psychiatry, 23-26 Aug 2018 in Grand Hyatt, Mumbai.

9. Quraishi R, Singh D, Ambekar A, Jain R, Rao R. Gamma gutamyl transferase measurement in dried serum spots. Poster presented at the 19^th congress of international society for biomedical research on alcoholism (ISBRA2018), 9-13 Sept 2018 in Kyoto, Japan.

10. Chatterjee B, Quraishi R, Rao R. Genetic aspects of addictive disorders. Symposium accepted at Annual National Conference of Indian Psychiatric Society 5-8 Feb 2018 Ranchi, Jharkhand.

11. Quraishi R. Genetic predictors and moderators of treatment research in substance use (alcohol use disorders). Symposium presented at National Conference on Addiction Psychiatry dated 29^th Nov 2017.

12. Quraishi R, Jain R, Ambekar A, Verma A, Gupta P. Feasibility of using filter paper as a matrix for drug screening in urine of substance users. Presented at 49^th Annual Conference of Indian Pharmacological Society” 21-23 Oct 2016.

13. Quraishi R, Jain R, Bera SC, Ambekar A. Association of alcohol use pattern with liver enzyme levels: report from a tertiary care treatment centre in India. Presented at World association of Social Psychiatry, 2016.

14. Jain R, Quraishi R, Verma A, Ambekar A. “Evaluation of Dried urine spot method for detection of BZD among substance users”. International Association of Medico Legal Experts (IAMLE), Jan 2016.

15. Jain R, Quraishi R, Verma A. “Evaluation of Dried urine spot method for detection of cotinine among Tobacco users”. National Institute on Drug Abuse (NIDA) International Forum, June 2015.

16. Quraishi R, Jain R, Balhara YPS. “Profile of nicotine use among alcohol dependent patients visiting a tertiary care treatment centre in North India” Presented at 11^thIndo Pacific Association of Law, Medicine & Science Congress 2013 (Inpalms 2013) 7^th-10^th October 2013 Kuala Lumpur, Malaysia

17. Jain R, Quraishi R, Verma A, Ambekar A. An Efficient Method for Detection of Opiate in Dried Urine Specimens among Opioid Users.11^thIndo Pacific Association of Law, Medicine & Science Congress 2013 (Inpalms 2013) 7^th-10^th October 2013 Kuala Lumpur, Malaysia

18. Quraishi R and Jain R. ANKKI /Taq A Genotyping from blood stored on filter paper. 40^th National Conference of Association of Clinical Biochemists of India 3^rd-6^th Dec, 2013, NASC, PUSA (N Delhi)

19. Quraishi R, Jain R, Pattanayak RD, Dhawan A. Biochemical and Haematological Profile of Inhalant users seeking treatment at a tertiary care centre in India. 65^th Annual National Conference of Indian Psychiatric Society. January 10-13, 2013, Bangalore, Karnataka, India

20. Balhara YPS, Jain R, Quraishi R.A comparative urinalysis based study of cannabis use among opioid dependent individuals on Opioid Substitution Therapy (OST) with buprenorphine or buprenorphine-naloxone combination”. 65^th Annual National Conference of Indian Psychiatric Society. January 10-13, 2013, Bangalore, Karnataka, India.

21. Quraishi R, Jain R, Pattanayak RD, Dhawan A. Profile of Inhalant users seeking treatment at a tertiary care centre in India. 39^th Annual National Conference of Indian Associate of Clinical Psychologists. February 18-20, 2013, AIIMS (N Delhi)

22. QuraishiR, Raka Jain, R.D. Pattanayak Effect of age on the biochemical parameters of alcohol dependent patients visiting a tertiary care treatment centre in India: A pilot study. 3^rd International conference on legal medicine, medical negligence and litigation in medical practice and 3^rd international conference in current trends in forensic sciences and forensic medicine and toxicology. IMALE- 2012 (3^rd - 5^th February, 2012)

23. Jain R, Quraishi R, Majumder P, and Pattanayak RD. Comparison of self-report and biological measures for alcohol, tobacco and illicit drug use in consecutive alcohol dependent patients visiting a tertiary care centre. IMALE- 2012 (3^rd - 5^th February, 2012)

24. Quraishi R and Jain R. Morphine recovery from dried urine specimens” 10^th Indo-Pacific Congress on Legal Medicine and Forensic Science. Inpalms 2010 (25^th - 30^th October, 2010)

10. Investigator/ Co-investigator in funded projects along with year completed/ongoing

1. Evaluation of Neurocognitive, Personality, Emotional, and Social Biomarkers as Candidate Endophenotypes for Opioid Use Disorder & their Relationship with Polymorphism in Opioid & Dopamine Receptor Genes: Implications for Prevention & Treatment. Co-PI (ICMR funded, 2021 ongoing)

2. Metabolic and addiction indices in Indian opioid dependent subjects on Buprenorphine-naloxone Maintenance treatment: A longitudinal study. Co-PI(ICMR funded, 2022-25)

3. Development and pilot testing of a biomarker feedback cognitive social health information programme during pregnancy. Co-PI(ICMR funded, 2022 ongoing)

4. A Cross-Sectional Study to Screen for Psycho-sexual Health Disorders and Measure Neurochemical Correlates in Gynaecology Cancer Survivors. Co- PI (AIIMS funded, 2021 ongoing).

5. HIV, Hepatitis B and C testing in individuals receiving agonist treatment for injecting drug use at a community clinic in Delhi: a cross sectional assessment of risk factors and seroprevalence”. Co-PI(AIIMS funded, 2021 ongoing)

6. An evaluation of mu opioid receptor gene polymorphism (A118G) and long term naltrexone treatment response in North-Indian alcohol dependent patients. Principal Investigator. ICMR funded study (2019-ongoing).

7. Assessment of clinical profile, mitochondrial DNA 10398, peripheral glucose utilization (HOMA-IR) and inflammation (TNF-a) in Matrilineal Bipolar Disorder. Co-PI(Intramural project, 2019 ongoing).

8. A functional polymorphism of dopamine beta hydroxylase gene and disulfiram treatment response in patients with alcohol dependence: A pilot exploratory study. Principal Investigator. (AIIMS funded Study (2018-20).

9. Biomarkers of Lithium response in Bipolar disorder: assessment of the clinical markers, peripheral blood based markers and structural neuroimaging markers (pertaining to gray matter volume) in individuals with bipolar disorder on long-term lithium prophylaxis. Co-Investigator. (2017 Ongoing).

10. Detection of New Psychoactive Substances among Substance Abuse Treatment Seekers in India: A Multi-centric Study. Co-Investigator. (Funded by Ministry of Revenue, GOI, 2017-22).

11. Feasibility of transporting blood/serum samples onto filter paper to screen for biomarkers of harmful alcohol use among opioid dependent patients on agonist maintenance treatment: A pilot study in community setting. (PI) (AIIMS funding) (2016-18).

12. Feasibility of transporting urine samples of drug users on filter paper for screening drugs of abuse: A pilot exploratory study. Co-PI (ICMR funded, 2012-15).
    

11. Investigator/Co-investigator in non-funded projects along with year and title completed/ongoing

1. A functional polymorphism of aldehyde dehydrogenase gene (rs671) and disulfiram treatment response in patients with alcohol dependence: A pilot exploratory study. PI (2020 ongoing).

2. Clinical laboratory profile of opioid dependent patients: A retrospective chart review study. (PI) (2019-20)

3. To explore and compare the association of various demographic, clinical and laboratory factors with Delirium Tremens (DT) among patients with Alcohol Dependence (AD), admitted with and without a diagnosis of DT, based upon review of clinical records. Departmental study. (2017-20) Principal Investigator.

4. A cross sectional study to measure the frequency of the BDNF Met66 allele in patients seeking treatment for alcohol use disorder. (MD Thesis, as co-supervisor, 2020).

5. A randomized double blind sham controlled trial for evaluating effectiveness and tolerability of high definition transcranial direct current stimulation in depression. (MD Thesis, as co-supervisor, 2020).
   

12. Thesis supervised for MD/ DM/PhD

- as guide (number only): 2 MD  

-as co-guide (number only): 2 DM, 5 MD, 2 Ph.D. (Member)

13. Awards and Honours:

1. Young psychiatrist award at 2nd International conference of Research and Education Center for mental Health and Psychiatry, Taiwan, July 2020. (2^nd Author, Findings from research study as PI).

2. On invitation authored a book chapter for The Royal Society of Chemistry, Cambridge, UK. 2017

3. Chaired sessions on Mental Health at World Congress of Social Psychiatry, 2016 and National Conference on Addiction Medicine, 2017.

4. Awarded travel grant from ICMR to attend; 11^thIndo Pacific Association of Law, Medicine & Science Congress 2013, Kuala Lumpur, Malaysia

5. Awarded travel grant from DST to attend American Association Clinical Chemistry, Annual meeting, USA 2005.

14. Any other relevant information

1. Managing the laboratory services to assess health damage in patients with substance use. It includes Chemistry, Hematology and Electrolyte measurements.

2. Looking after the drugs of abuse testing laboratory and therapeutic drug monitoring.

3. The NDDTC Laboratory has the state of art instruments to test New Psychoactive substance.

4. The genetics laboratory at NDDTC is involved in research pertaining treatment response to the therapeutic interventions and the genetic vulnerability towards drugs use and abuse.

5. Running ‘External Quality Control Programme’ for all investigations at NDDTC, Monthly reporting of blinded external sample for the Chemistry, Hematology & electrolytes parameters.

6. Working as Reviewer

• Indian Journal of Psychiatry.

• Indian Journal of Medical Research.

• Journal of Substance Abuse & Treatment.

• Journal of Substance Abuse.

• Journal of Pharmacology and Pharmacy.

• Indian Journal of Clinical Biochemistry.